Company: ZCARW
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076590
Chunk: 107

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 107
---
 the same securities by promoters and broker-dealers
after prices have been manipulated to a desired level, resulting in investor losses. Our management is aware of the abuses that have occurred
historically in the penny stock market. Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers
who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from
being established with respect to our securities.

On August 5, 2025, we received
notice from the OTCQX U.S. tier of OTC Markets Group that our Global Market Capitalization has been below the $5.0 million minimum for
more than 30 consecutive calendar days, and that we therefore no longer satisfy OTCQX continued qualification standards. We have a 90-calendar-day
cure period, expiring November 3, 2025, during which we must maintain a Global Market Capitalization of at least $5.0 million for 10 consecutive
trading days to regain compliance. We may be unable to regain or maintain compliance within the required timeframe, and any removal from
OTCQX could further reduce the liquidity and market price of our common stock and negatively affect our access to capital. Efforts to
regain compliance could require financing or other corporate actions that may be dilutive or involve other risks.

We may not regain compliance with OTCQX continued qualification
standards within the required timeframe, and any removal from OTCQX could materially and adversely affect the liquidity and market price
of our common stock and our access to capital.

On August 5, 2025, we received a written notice from the OTCQX U.S. tier of OTC Markets Group stating that our Global Market Capitalization
has remained below the minimum $5.0 million required under Section 2.1(B) of the OTCQX Rules for U.S. Companies for more than 30 consecutive
calendar days and, as a result, we no longer satisfy the OTCQX standards for continued qualification. Under those rules, we have a 90-calendar-day
cure period, expiring on November 3, 2025, to regain compliance by maintaining a Global Market Capitalization of at least $5.0 million
for 10 consecutive trading days. There can be no assurance that the Company will regain or thereafter maintain compliance within the
cure period, if at all.

If the Company